rituximab popular tagged News at allvoices.com

rituximab news

News tagged with “rituximab”. Found: 115 tagged news reports.
 

Your Search Returned 115 tagged news reports

 
Related Tags:

Brussels :: Belgium | 2 days ago

Credibility Credibility of 5

Gazyvaro, a new, type II, glycoengineered monoclonal antibody, is marketed as Gazyva outside of the EU and Switzerland. It is designed to attach to CD20, a protein found only on B cells and it attacks targeted cells both directly and together with

Tags:

London :: United Kingdom | 3 days ago

Credibility Credibility of 5

Food and Drug Administration on July 23, 2014 for the treatment of three B-cell blood cancers...Food and Drug Administration on July 23, 2014 for the treatment of three B-cell blood cancers. "We are pleased to partner with Gilead and be included in

Tags:

Alexandria :: VA :: USA | 7 days ago

Credibility Credibility of 5

On Wednesday, the biotech got Zydelig approved to treat three different B-cell blood cancers: chronic lymphocytic leukemia, follicular B-cell non-Hodgkin lymphoma, and small lymphocytic lymphoma. All three indications are for patients that have

Tags:

London :: United Kingdom | 7 days ago

Credibility Credibility of 5

is a significant investor in Onco360...Food and Drug Administration (FDA) for the treatment of three different B-cell blood cancers: 1. In combination with rituximab for patients with relapsed chronic lymphocytic leukemia (CLL) for whom rituximab

Tags:

Brussels :: Belgium | 1 month ago

Credibility Credibility of 5

MCL is a rare and aggressive blood cancer that usually occurs in older adults. Mantle Cell Lymphoma reinforce our belief that this therapy has the potential to be an important option in the treatment of this cancer." Today's submission is based on

Tags:

London :: United Kingdom | 1 month ago

Credibility Credibility of 5

Following the launch of Herceptin SC in September 2013, MabThera SC is the second novel subcutaneous formulation of one of Roche's oncology products using Halozyme's patented EnhanzeTM (recombinant human hyaluronidase) technology to be launched in

Tags:

Ascó :: Spain | 1 month ago

Credibility Credibility of 5

S&P Biotech Index up 25% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that made waves in

Tags:

London :: United Kingdom | 2 months ago

Credibility Credibility of 5

L US-based biopharmaceutical firm Inhibikase Therapeutics has received orphan drug designation from the US Food and Drug Administration (FDA) for imatinib to treat Progressive Multifocal Leukoencephalopathy (PML). PML is a rare side effect of small

Tags:

London :: United Kingdom | 2 months ago

Credibility Credibility of 5

GSK said that there were no differences in adverse events (AEs) leading to treatment discontinuation, Grade >3 AEs, severe adverse events (SAEs), or fatal SAEs between the treatment arms. Results demonstrate that there were more dose interruptions

Tags:

San Diego :: CA :: USA | 5 months ago

Credibility Credibility of 5

For a young biotech company looking to woo investors, it helps to have promising products...Receptos, a developer of drugs for autoimmune disorders such as multiple sclerosis, has both. That combination helps explain why shares of the La Jolla

Tags:



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.